Panacos Pharmaceuticals Inc (Grey Market:PANC)

0.003
Data as of Apr 17
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.01
+15.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$160.9K

Company Description

Panacos Pharmaceuticals, Inc. is a development stage company engaged in the discovery and development of small-molecule oral drug which is designed to treat Human Immunodeficiency Virus and other major human viral diseases. Its primary product is Bevirimat which is an oral human immunodeficiency virus which provides a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in March 2005 and is headquartered in Watertown, MA.

Contact Information

Panacos Pharmaceuticals, Inc.
134 Coolidge Avenue
Watertown Massachusetts 02495
P:(617) 926-1551
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

John R. BarrPresident & Chief Executive Officer
Thomas T. HigginsChief Financial Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.